Patients win over patents

Monday was a remarkable day for cancer patients in India. To them, the country said — “we care.” I am talking about the astounding decision by Justice Sridevan of the Intellectual Property Appellate Board (IPAB) permitting Natco Pharma Ltd. to continue making and selling a generic version of Bayer’s kidney cancer drug Nexavar.

Read Full Story>>